#Psychedelics #DepressionTreatment #ClinicalResearch
www.medscape.com
Mixed Results for Psilocybin as Blinding Concerns Remain
Two new major studies tackle what many researchers believe to be the central unresolved issue in the assessment of psychedelics as treatment for depression: Whether the apparent benefits are inflated by failures of blinding.
#MentalHealth #DepressionTreatment #Neurotechnology
newatlas.com
First US at-home depression kit on its way after trial shows benefits in weeks
In the trial, people wore the headset once a day for about 20-30 minutes per session
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major depressive disorder (MDD).
